Anti-PAD4 autoantibodies in rheumatoid arthritis: Levels in serum over time and impact on PAD4 activity as measured with a small synthetic substrate

Rheumatology International

Volumn 32, Issue 5, 2012, Pages 1271-1276

  Pollmann, Sylvie ^a   Stensland, Maria ^a   Halvorsen, Eirik Hornes ^a   Sollid, Ludvig M ^a   Kvien, Tore K ^b   Fleckenstein, Burkhard ^a   Molberg, Øyvind ^a,c  

^a UNIVERSITY OF OSLO   (Norway)

^b DIAKONHJEMMET HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Autoantibodies; Citrulline; Peptidylarginine deiminase 4; Rheumatoid arthritis

Indexed keywords

AUTOANTIBODY; BENZOYLARGININE 4 NITROANILIDE; IMMUNOGLOBULIN G; PROTEIN ARGININE DEIMINASE; PROTEIN ARGININE DEIMINASE AUNTOANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ARGININE; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CATALYSIS; DISEASE PROGRESSION; HUMANS; HYDROLASES; IMMUNOASSAY; IMMUNOGLOBULIN G; KINETICS; NORWAY; SEVERITY OF ILLNESS INDEX; SUBSTRATE SPECIFICITY;

EID: 84863634836     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-010-1765-y     Document Type: Article

References (21)

1. Molberg O, Sollid LM (2006) A gut feeling for joint inflammation\using coeliac disease to understand rheumatoid arthritis. Trends Immunol 27:188-194
2. Klareskog L, Ronnelid J, Lundberg K, Padyukov L, Alfredsson L (2008) Immunity to citrullinated proteins in rheumatoid arthritis. Annu Rev Immunol 26:651-675
3. Zendman AJ, van Venrooij WJ, Pruijn GJ (2006) Use and significance of anti-CCP autoantibodies in rheumatoid arthritis. Rheumatology (Oxford) 45:20-25
4. Nikolaisen C, Rekvig OP, Nossent HC (2007) Diagnostic impact of contemporary biomarker assays for rheumatoid arthritis. Scand J Rheumatol 36:97-100
5. Auger I, Balandraud N, Rak J, Lambert N, Martin M, Roudier J (2009) New autoantigens in rheumatoid arthritis (RA): screening 8268 protein arrays with sera from patients with RA. Ann Rheum Dis 68:591-594
6. Halvorsen EH, Pollmann S, Gilboe IM et al (2008) Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity. Ann Rheum Dis 67:414-417
7. Halvorsen EH, Haavardsholm EA, Pollmann S et al (2009) Serum IgG antibodies to peptidylarginine deiminase 4 predict radio-graphic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents. Ann Rheum Dis 68:249-252
8. Harris ML, Darrah E, Lam GK et al (2008) Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis. Arthritis Rheum 58:1958-1967
9. Takizawa Y, Sawada T, Suzuki A, Yamada R, Inoue T, Yamamoto K (2005) Peptidylarginine deiminase 4 (PADI4) identified as a conformation-dependent autoantigen in rheumatoid arthritis. Scand J Rheumatol 34:212-215
10. Stensland ME, Pollmann S, Molberg O, Sollid LM, Fleckenstein B (2008) Primary Sequence, together with other factors, influence peptide deimination by peptidylarginine deiminase-4. Biol Chem 390:99-107
11. Nakashima K, Hagiwara T, Ishigami A et al (1999) Molecular characterization of peptidylarginine deiminase in HL-60 cells induced by retinoic acid and 1alpha, 25-dihydroxyvitamin D(3). J Biol Chem 274:27786-27792
12. Kiraly R, Vecsei Z, Demenyi T, Korponay-Szabo IR, Fesus L (2006) Coeliac autoantibodies can enhance transamidating and inhibit GTPase activity of tissue transglutaminase: dependence on reaction environment and enzyme fitness. J Autoimmun 26:278-287
13. Hoppe B, Haupl T, Gruber R et al (2006) Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study. Arthritis Res Ther 8:R34
14. Ikari K, Kuwahara M, Nakamura T et al (2005) Association between PADI4 and rheumatoid arthritis: a replication study. Arthritis Rheum 52:3054-3057
15. Plenge RM, Padyukov L, Remmers EF et al (2005) Replication of putative candidate-gene associations with rheumatoid arthritis in >4, 000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet 77:1044-1060
16. Rantapaa-Dahlqvist S, de Jong BA, Berglin E et al (2003) Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 48:2741-2749
17. Daouk GH, Palsson R, Arnaout MA (1995) Inhibition of pro-teinase 3 by ANCA and its correlation with disease activity in Wegener's granulomatosis. Kidney Int 47:1528-1536
18. Kohno Y, Yamaguchi F, Saito K, Niimi H, Nishikawa T, Hosoya T (1991) Anti-thyroid peroxidase antibodies in sera from healthy subjects and from patients with chronic thyroiditis: differences in the ability to inhibit thyroid peroxidase activities. Clin Exp Immunol 85:459-463
19. Auger I, Martin M, Balandraud N, Roudier J (2010) Rheumatoid arthritis-specific autoantibodies to peptidyl arginine deiminase type 4 inhibit citrullination of fibrinogen. Arthritis Rheum 62:126-131
20. Arita K, Hashimoto H, Shimizu T, Nakashima K, Yamada M, Sato M (2004) Structural basis for Ca(2?)-induced activation of human PAD4. Nat Struct Mol Biol 11:777-783
21. Engel MF, van Mierlo CP, Visser AJ (2002) Kinetic and structural characterization of adsorption-induced unfolding of bovine alpha-lactalbumin. J Biol Chem 277:10922-10930